AMLX vs ON · rev $87.4M vs P/E 36, rev $3.12B
Amylyx Pharmaceuticals Inc (AMLX) versus ON Semiconductor Corporation (ON) — a side-by-side from cached financials, not a winner call.
Amylyx Pharmaceuticals Inc (AMLX) is a biotechnology company listed on US.
ON Semiconductor Corporation (ON) is a semiconductors company listed on US.
Latest reported AMLX revenue for 2024-12-31 was $87.4M. Net income was -$301.7M. Revenue was down 77.1% from 2023-12-31 to 2024-12-31. AMLX currently screens at market cap $561.6M.
Latest reported ON revenue for 2026-07-03 was $3.12B. Net income was $193.4M. ON currently screens at market cap $21.90B and trailing P/E 36.4.
AMLX currently screens at market cap $561.6M. ON currently screens at market cap $21.90B and trailing P/E 36.4.
Not investment advice. Open the AMLX and ON stock pages for the full models.
Not investment advice.